Cleared Traditional

K053527 - SPECTRA HAIR REMOVAL LASER

K053527 is an FDA 510(k) clearance for SPECTRA HAIR REMOVAL LASER, manufactured by Spectragenics, Inc.. The device is a Class 2 General & Plastic Surgery device with product code GEX cleared through the Traditional 510(k) pathway after a 774-day FDA review.

K053527 · Spectragenics, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2008
Decision
774d
Days
Class 2
Risk

K053527 is an FDA 510(k) clearance for the SPECTRA HAIR REMOVAL LASER. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Spectragenics, Inc. (Washington, US). The FDA issued a Cleared decision on February 1, 2008 after a review of 774 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General & Plastic Surgery submissions.

View all Spectragenics, Inc. devices

FDA 510(k) Submission Details - K053527

510(k) Number K053527 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 19, 2005
Decision Date February 01, 2008
Days to Decision 774 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
659d slower than avg
Panel avg: 115d · This submission: 774d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GEX Device Classification - Class 2, Special Controls

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 1841
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K053527.
AFFIRM WITH XPL HANDPIECE AND ER:YAG LASER MODULE
K080006 · Cynosure, Inc. · Feb 2008
15W CERALAS D 1470NM DIODE LASER
K073063 · Biolitec, Inc. · Feb 2008
WATERLASE AND WATERLASE MD
K071363 · Biolase Technology, Inc. · Feb 2008
CYNOSURE SMARTLIPO MULTIWAVLENGTH LASER
K080121 · Cynosure, Inc. · Jan 2008
WATERLASE MD DERM
K071734 · Biolase Technology, Inc. · Jan 2008
CERALAS D 980NM DIODE LASER, MODELS D15 AND D25
K072779 · Biolitec, Inc. · Jan 2008